Phase ll Study of HEC585 in Patients With IPF

Clinical trial NCT05060822 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05060822
Sponsor: Sunshine Lake Pharma Co., Ltd.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis

Start date: 2021-06-30
Primary completion: 2025-07-16
Enrollment: 270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.